Related Experiment Video
Updated: Dec 8, 2025

04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
15.0K
Using Lower Amplitudes to Maintain Effective High Dose Spinal Cord Stimulation Therapy (SCS Dosing Pilot Study)
Amr O El-Naggar1, Christopher L Reis2, John A Hatheway3
1Drez One, Somerset, KY, USA.
Neuromodulation : Journal of the International Neuromodulation Society
|September 18, 2020
Summary
High-dose spinal cord stimulation (SCS) can maintain pain relief and patient satisfaction at low amplitudes. Most patients with chronic pain found 20% perception threshold amplitude effective for high-dose SCS therapy.
Area of Science:
- Neurosurgery
- Pain Management
- Neuromodulation
Background:
- Spinal cord stimulation (SCS) is a proven therapy for chronic pain.
- Limited data exists on minimum amplitude requirements for high-dose SCS parameters.
- This study addresses the need for guidance on amplitude settings for high-dose SCS.
Purpose of the Study:
- To determine the minimum amplitude required to maintain patient satisfaction and pain relief during high-dose SCS.
- To investigate amplitude dose-response in patients treated with 1000 Hz and 90 μsec SCS parameters.
Main Methods:
- Patients with chronic pain receiving high-dose SCS (1000 Hz, 90 μsec) were enrolled.
- Participants underwent blinded amplitude titration at 80%, 60%, 40%, and 20% of their baseline perception threshold.
- Patient satisfaction and pain scores (VAS) were assessed at each amplitude level.
Main Results:
- The majority of patients maintained therapy satisfaction (70%) and pain relief (63.3%) at 20% perception threshold amplitude.
- A significant portion of patients required lower amplitudes than initially expected for effective pain management.
- Five patients needed their original baseline amplitude to sustain therapy effectiveness.
Conclusions:
- High-dose SCS can be effective at amplitudes significantly below the perception threshold in a majority of patients.
- These findings suggest potential for optimizing SCS therapy by reducing amplitude while maintaining efficacy.
- Further research can explore the long-term effects and patient variability in response to low-amplitude high-dose SCS.

